The Price of Binge Watching: Subclinical Atherosclerosis and Sleep Quality

Fragmented sleep and lower sleeping time have a higher risk of subclinical atherosclerosis in multiple territories. These results highlight the importance of good sleeping habits for good health and against cardiovascular disease. This comes out when binge watching online series on TV or any mobile device has become the norm. Online “streaming” is silently stressing our arteries out.

The aim of this study was to assess the relation between sleep parameters and subclinical atherosclerosis in an asymptomatic middle age population. In addition, researchers looked at conventional risk factors, eating habits, etc.

 

Sleep patterns were assessed (actigraphic measure) during 7 days in 3974 participants (45.8 ± 4.3 years; 62.6% men) and four groups were defined: very short (< 6 hours), short (6 a 7 horas), reference duration (7 to 8 hours) and prolonged sleep (>8 hours).



Read also: Anticoagulation Plays a Controversial Role in TAVR.


Carotid and femoral 3D vascular ultrasound was performed to assess Noncoronary atherosclerosis and coronary calcification.

 

After adjusting for conventional risk factors, very short sleep duration was associated with much higher atherosclerosis than reference duration sleep (OR: 1.27; CI 95%: 1.06 to 1.52; p=0.008). Participants with fragmented sleep also presented higher atherosclerosis burden in noncoronary territories.


Read also: The “Ten Commandments” of Myocardial Revascularization According to Europe.


Coronary calcification was similar across all groups.

 

Conclusion

Short sleep and fragmented sleep are independently associated with subclinical atherosclerosis in multiple territories. Sleeping well should be included in the advice “pack” we give our patients.

Original title: Association of Sleep Duration and Quality with Subclinical Atherosclerosis.

Reference: Fernando Domínguez et al. J Am Coll Cardiol 2019;73:134–44.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...